| Gene: | FLT3 |
| GeneID: | ENSG00000122025 |
| Chrom: | 13 |
| Start position: | 28003274 |
| End position: | 28100592 |
| Pathway: | Hematopoietic cell lineage |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.0961253 |
| Number of nsSNPs: | 3 |
| nsSNPs in gene: | rs12872889
rs1933437
rs35958982 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 1 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Recurrently mutated in 2 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 2112.70 (Percentile rank: 98.02%) |
| PubTator score: | 1525.44 (Percentile rank: 97.68%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
